Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC

Name: Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC
Published: 2018
License: Public Domain

ERYtech Pharma · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

asparaginase cancer fluorouracil paclitaxel

pancreatic adenocarcinoma, pancreatic, cancer, asparaginase, gemcitabine, abraxane, asparagine depletion, onivyde, nab-paclitaxel, folinic acid, fluorouracil, irinotecan

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC

Related documents